Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

#24-38 Trading halt in GRANGEX AB

NGM has decided to halt the trading in the shares of GRANGX AB effective immediately. Trading will be halted until further notice in accordance with Chapter 11, Section 12 of the Securities Market Act. The Financial Supervisory Authority has been notified about the trade halt and has decided that it will remain until further notice in accordance with Chapter 22, Section 1 of the Securities Market Act.   Information regarding the affected instruments:   Listing name: GRANGEX Exchange symbol: GRANGX ISIN-code: SE0018014243 CFI-code: ESVUFR FISN-code: GRANGEX/SH

White & Case advises Nobia on multiple strategic transactions

Global law firm White & Case LLP has advised Nobia (the “Company”), a long-term client with whom the firm have shared a strong corporate memory together, on a list of significant strategic transactions.Nobia is a leading European kitchen specialist which develops and sells kitchen solutions through a number of brands across the Nordics, UK and Europe. The Company has approximately 5,000 employees and net sales of about SEK 13.4 billion. Over the years, White & Case’s Stockholm team has followed the growth, development and success of Nobia. We continue to partner closely with Nobia every

Calquence combination improved PFS in 1L MCL

02 May 2024 Calquence combination regimen demonstrated statistically significant and clinically meaningful improvement in progression-free survival in 1st-line mantle cell lymphoma in ECHO Phase III trial First BTK inhibitor to show favourable trend in overall survival vs. standard-of-care chemoimmunotherapy in this setting Positive high-level results from an interim analysis of the ECHO Phase III trial showed AstraZeneca's Calquence (acalabrutinib) in combination with standard-of-care chemoimmunotherapy, bendamustine and rituximab, demonstrated a statistically significant and

Third-time recognition for Atea as climate leader in Europe

(OSLO, NORWAY) The Financial Times, in collaboration with data powerhouse Statista, has again recognized Atea among European companies making significant strides in reducing their greenhouse gas emissions. This is the third time Atea has earned this prestigious recognition. In the published list, Europe’s Climate Leaders, the emissions data of tens of thousands of European companies were scrutinized. Atea continues to be among the firms successfully cutting their greenhouse gas emissions relative to revenue. Atea’s CEO, Steinar Sønsteby, welcomed this sustained ranking: “We’re honored

Christian Rynning-Tønnesen Appointed New Senior Partner at ICP and CEO of ICP Infrastructure

Industry Capital Partners (ICP), Aker’s asset management company, today announced the appointment of Christian Rynning-Tønnesen as new Senior Partner and CEO of ICP Infrastructure. Rynning-Tønnesen, who recently stepped down as CEO of Statkraft, Europe’s largest producer of renewable energy and a leading player in global energy markets, brings extensive experience and expertise to ICP.“Having had the privilege of knowing and collaborating with Christian Rynning-Tønnesen for many years during his tenure as CEO of Statkraft, I can attest to the remarkable achievements attained under his

Toxic chemicals can be detected with new AI method

Swedish researchers at Chalmers University of Technology and the University of Gothenburg have developed an AI method that improves the identification of toxic chemicals – based solely on knowledge of the molecular structure. The method can contribute to better control and understanding of the ever-growing number of chemicals used in society, and can also help reduce the amount of animal tests. The use of chemicals in society is extensive, and they occur in everything from household products to industrial processes. Many chemicals reach our waterways and ecosystems, where they

Boliden incorporates validated climate goals in sustainability linked credit facilities agreement

Boliden, as one of the first mining and metals companies in the world, has incorporated and linked climate goals validated by Science Based Targets initiative (SBTi) into an existing revolving credit facilities agreement (RCF). The RCF totals EUR 850 m and now includes Sustainability Performance Targets aligned with Boliden´s climate goals, being emission reductions corresponding to 42 percent (Scope 1 and 2) as well as emission reductions of 30 percent (Scope 3) by 2030, base year 2021. “Base metals are needed for Europe’s transition towards climate-friendly societies. As a provider of

Reminder: Invitation to presentation of Orkla’s first quarter 2024 results, Friday 3 May

Orkla will report its first quarter 2024 results on Friday, 3 May 2024 at 7:00 a.m. CEST.The quarterly report and the presentation material will be available at this time at: https://investors.orkla.com.The quarterly results will be presented at 8:00 a.m. CEST at the Orkla House, Drammensveien 149, Oslo.  The presentation and subsequent Q&A session will be held in English and may be viewed in a live webcast at https://investors.orkla.com (direct link: Q1 2024 presentation • WN Event (webcast.no) ) or followed by

SciBase supports clinicians during US Skin Cancer Awareness Month

STOCKHOLM, SWEDEN, - May 02, 2024 - SciBase Holding AB ("SciBase") [STO: SCIB], a pioneer in skin cancer detection and prevention, and prediction in dermatology, further deepens their commitment to patients and dermatologists during US Skin Cancer Awareness Month by highlighting the importance of early detection and prevention of skin cancer and helping improve outcomes for clinicians and patients.The entire month of May is dedicated to Skin Cancer Awareness to draw focus on the most common cancer in the United States — skin cancer.  It is estimated that more than 9,500 people are diagnosed

Foxway has appointed a new CFO

Foxway strengthened its management team with the appointment of Anders Wallin as the new Chief Financial Officer (CFO). With extensive experience across multiple industries, Anders brings valuable expertise in M&A and business development to the role. His leadership will be crucial in guiding and advancing Foxway's financial operations, playing a pivotal role in the company's ongoing growth and geographical expansion efforts."Me and the team are delighted to welcome Anders to Foxway. With his extensive experience as a CFO in rapidly growing organizations, Anders brings valuable expertise to

Transaction in Own Shares

    2 May 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |01/05/2024|+---------------------------------------------------------------

Interim Report First Quarter 2024

STENOCARE A/SNASDAQ FIRST NORTH GROWTH MARKET, DENMARKTICKER: STENOSTENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2024 – 31.03.2024. The report, which has not been reviewed by the Company’s auditors, is attached to this release and is also available on https://stenocare.com/investor-relations/ Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: ”Stenocare has successfully managed to launch new approved products and sales has seen positive growth during Q1 2024" [](KDKK) 01.01.2024 01.01.2023 01.01.2023 01.12.2022

Implantica’s RefluxStop™ is now available in seven hospitals in Spain adding two new centers of excellence

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces that Dra. Beatriz Guil of Universitario de Canarias in the Canary Islands and Dr. Carlos Milliani of Universitario de Fuenlabrada in the Madrid Region are offering their patients the RefluxStop™ procedure.More patients in Spain will have access to the innovative RefluxStop™ procedure now, given that a total of seven anti-reflux centers of excellence in the country regularly perform the procedure. “It’s a new day we’ve long awaited in the world of surgical GERD treatment,”

Q1 2024 Trading Update

2 May 2024 International Personal Finance plc Q1 2024 trading update International Personal Finance plc ("IPF" or the "Group") is helping to build a better world through financial inclusion by providing affordable credit products and insurance services to underserved consumers across nine markets. Highlights · Strong first quarter performance underpins our confidence in delivering our financial plan in 2024.· Customer lending growth of 5%, excluding Poland, with demand improving as the quarter progressed.· Good year-on-year net receivables growth of 11% (at

Vestas – Interim Financial Report, First Quarter 2024

Vestas Wind Systems A/S, Aarhus, 2 May 2024Company Announcement no. 07/2024 Summary: Quarterly revenue of EUR 2.7bn with an EBIT margin before special items of (2.5) percent. Order intake of 2.3 GW and record-high combined order backlog of EUR 61.0bn. Full-year guidance maintained. In the first quarter of 2024, Vestas generated revenue of EUR 2,681m – a decrease of 5.2 percent compared to the year-earlier period. EBIT before special items amounted to EUR (68)m, resulting in an EBIT margin before special items of (2.5) percent. The underlying EBIT margin increased with 1.5 percentage

Interim report Q1: Strong development within Rock Sweden and positive effects of cost adaptions

January – March 2024 · Net sales decreased by 18% and amounted to SEK 751 (912) million · Organic growth amounted to -21 (21) % · Adjusted EBIT amounted to SEK 24 (51) million with a margin of 3.2 (5.6) % · Cash flow from operating activities amounted to SEK 51 (93) million · Earnings per share for the period before and after dilution amounted to SEK -0.26 (0.29) - The very low activity in housing construction and its surrounding effects continue to negatively impact on the group's financial performance, particularly our revenue. However, ongoing, and initiated

ADDvise receives order worth USD 11.3 million

MRC Systems, an ADDvise Group company, has received an order from leading Omani biopharmaceutical company Opal Bio Pharma. The initial order value amounts to USD 11.3 million with an extension option amounting to an additional USD 6.8 million.   The order involves the design, supply, installation and validation of cleanroom panelling, HVAC and accessories for a biopharmaceutical production and R&D facility based outside Muscat, Oman. The project is scheduled for completion by the end of 2025.   “One of the Group’s largest orders to date, this exciting project further cements MRC’

Wihlborgs to build new facility for Caldic who is co-locating to Malmö

Wihlborgs has signed a 20-year agreement with the food solutions company Caldic Ingredients Nordic for a new 10,000 m² facility at Galoppen 1 in Fosie, eastern Malmö. Caldic is moving production as well as offices to the facilities, creating around 90 jobs. Occupancy will take place in autumn 2025.Caldic is one of the world’s top players in special ingredients for food, pharmaceuticals, personal care and industrial products. The company has international headquarters in Rotterdam and approximately 4,000 employees around the world. The Nordic operations are headquartered in Frihamnen in

(Reminder) Invitation to Capital Markets Day, May 13, 2024

Zurich, May 2, 2024: Kongsberg Automotive ASA is pleased to invite investors, analysts, media and other stakeholders to its Capital Markets Day, Monday May 13, 2024 in Oslo. The event will take place at Thon Hotel Vika Atrium in Munkedamsveien 45. The event starts at 13:00 CET and is expected to last until 16:30 CET.Light refreshments will be served. The event will include presentations on the company’s strategy, goals, and operations by key executives at Kongsberg Automotive. Speakers will be: · Linda Nyquist-Evenrud, President & CEO · Frank Heffter, CFO · Christian

Nordic Outlook: Mixed situation as central banks show true colours

So far in 2024, the growth outlook has improved a bit. The United States has again reported surprisingly strong growth, but also worrisome inflation setbacks. The inflation downtrend is alive but unstable, persuading central banks to wait longer and cut key rates more slowly. In a deteriorating geopolitical situation with constant new military, political and economic conflicts, the world remains unpredictable. In Sweden, rapidly falling inflation is opening the way for a clear shift in both fiscal and monetary policy and a strong recovery in GDP in 2025. The Riksbank will cut its policy

Salmon Evolution ASA: Invitation to presentation of results for the first quarter 2024

Salmon Evolution will present the first quarter 2024 results followed by a Q&A session, on Tuesday 7 May 2024 08:00 CET, at Hotel Continental in Oslo. A delicious sashimi buffet with salmon from Indre Harøy will be served from 07:45 CET. Note: The presentation will take place in Teatersalen. Participants may also follow the presentation and submit questions through a live webcast available on www.salmonevolution.no, or with the following link: https://events.webcast.no/salmon-evolution/OEpmPDaoyhi5siPjdg0b/4N4FewYC7AMYtNn8F97N The presentation and Q&A will be held in English by CEO

Integrum expands its product offering to the United Kingdom market

Mölndal, Sweden – May 2, 2024 — Integrum (publ) (Nasdaq First North Growth Market: INTEG B) announces that the company has entered a commercial agreement with LEDA Orthopaedics Ltd., a local medical device distributor specialized in niche trauma implants, hand surgery prostheses and unique solutions for orthopaedic procedures, to introduce OPRA[TM] Implant System in the United Kingdom.As part of Integrum's efforts to expand the availability of the OPRA™ Implant System to new geographical markets, the company has as of today initiated a distribution agreement in the United Kingdom with LEDA

Woodsafe's WRD acquires Designtech Solutions

Västerås-based Woodsafe Group establishes itself in northern Sweden. The Group's research company WRD acquires Designtech Solutions AB in Luleå.Woodsafe Group has long been a leader in fire retardant impregnation. To further consolidate this position, the Group recently started the research company Woodsafe Research & Development AB (WRD). Through the acquisition of Designtech Solutions, the new company will increase the competence and quality of its R&D operations.  "It's very positive that we can strengthen our organization. Woodsafe has had a fruitful collaboration with Designtech

There are no items matching the current filter
There are no more items matching the current filter
Back to top